BACHADON BO‘YNI DISPLAZIYASINI KELIB CHIQISH SABABLARI VA DAVOLASH USULLARI
Keywords:
Cervical dysplasia, Cervical intraepithelial neoplasia (CIN), HPVAbstract
Cervical dysplasia, or cervical intraepithelial neoplasia (CIN), is a precancerous condition marked by abnormal cellular changes in the cervical epithelium. The study aims to identify its causes, risk factors, diagnostic approaches, and modern treatment options. Human papillomavirus (HPV) infection is the predominant cause, with other contributing factors such as smoking, immune suppression, and prolonged hormonal contraceptive use. Diagnostic advancements like HPV testing and colposcopy have enhanced early detection rates. Treatment options range from conservative management for low-grade lesions to surgical procedures for advanced cases. Preventive strategies, especially HPV vaccination, show promise in reducing disease prevalence.
Downloads
References
1. Arbyn, M., et al. (2020). "HPV screening: Progress and challenges." The Lancet Oncology, 21(5), 631-640.
2. Saslow, D., et al. (2018). "Screening guidelines for cervical cancer prevention." CA: A Cancer Journal for Clinicians, 68(4), 312-317.
3. Basu, P., et al. (2019). "The role of HPV vaccines in cervical dysplasia prevention." International Journal of Cancer, 145(6), 1401-1410.
4. Moscicki, A. B., et al. (2021). "Cervical dysplasia: Pathophysiology and clinical management." Obstetrics & Gynecology Clinics of North America, 48(3), 543-556.
5. WHO (2022). "Comprehensive guide to cervical cancer prevention and control." World Health Organization Guidelines.
6. Solomon, D., et al. (2020). "The impact of HPV testing on cervical dysplasia diagnosis." American Journal of Obstetrics & Gynecology, 223(3), 299-307.
